NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will present at the Bank of America and Merrill Lynch Health Care Conference on Wednesday, May 13, 2009 in New York. Lamberto Andreotti, president and chief operating officer of Bristol-Myers Squibb, will make a formal presentation about the company at 12:40 p.m. ET on May 13.
As part of the presentation, Mr. Andreotti is expected to confirm the company’s earnings guidance.
Investors and the general public are invited to listen to a live webcast of the presentation at http://investor.bms.com. Materials related to the presentation will be available at the same website at the start of the live webcast. An archived edition of the presentation will be available later that day.
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to extend and enhance human life.
This press release contains “forward-looking statements” as that term is defined in the Private Securities Litigation Reform Act of 1995 regarding the company's financial performance. Such forward-looking statements are based on current expectations and involve inherent risks and uncertainties, including factors that could delay, divert or change any of them, and could cause actual outcomes and results to differ materially from current expectations. No forward-looking statement can be guaranteed. Forward-looking statements in the press release should be evaluated together with the many uncertainties that affect Bristol-Myers Squibb’s business, particularly those identified in the cautionary factors discussion in Bristol-Myers Squibb’s Annual Report on Form 10-K for the year ended December 31, 2008, its Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Bristol-Myers Squibb undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.
Bristol-Myers Squibb CompanyMedia:Brian Henry, 609-252-3337brian.henry@bms.comorInvestors:John Elicker, 609-252-4611john.elicker@bms.com